Plant biotechnologists have a love-hate relationship with the phenomenon known as posttranscriptional gene silencing (PTGS), a mechanism by which plant cells shut down the expression of highly ...
AstraZeneca has announced a collaboration with UK biotech Silence Therapeutics to develop gene silencing drugs for cardiovascular, renal, metabolic and respiratory diseases. The deal could see AZ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback